CAPTOPRIL: A NEW TREATMENT FOR RHEUMATOID ARTHRITIS?
Identifieur interne : 003655 ( Main/Merge ); précédent : 003654; suivant : 003656CAPTOPRIL: A NEW TREATMENT FOR RHEUMATOID ARTHRITIS?
Auteurs : M. F. R. Martin [Royaume-Uni] ; F. Mckenna [Royaume-Uni] ; H. A. Bird [Royaume-Uni] ; K. E. Surrall [Royaume-Uni] ; J. S. Dixon [Royaume-Uni] ; V. Wright [Royaume-Uni]Source :
- The Lancet [ 0140-6736 ] ; 1984.
English descriptors
- Teeft :
- Angiotensin, Arthritis, Arthritis rheum, Arthritis symptoms, Articular index, Captopril, Captopril therapy, Cigarette smoke, Clinical improvement, Clinical response, Clinical studies, Clinical variables, Gastrointestinal tracts, Human cells, Human model screening system, Hydrogen peroxide, Hydroxyl, Hypertension, Hypertensive patients, Immunochemical quantitation, Laboratory variables, Lancet, Morning stiffness, Mucus, Mucus layers, Night sweats, Open study, Other saards, Oxygen radicals, Plasma viscosity, Potential toxicity, Prostaglandin, Prostaglandin production, Rank test, Reactive species, Rheumatoid, Rheumatoid arthritis, Significant changes, Sodium aurothiomalate, Such cells, Surface epithelium, Table matrix.
Abstract
Abstract: Captopril, an inhibitor of angiotensin converting enzyme, is prescribed for hypertension. Its molecular structure shares features with D-penicillamine, in that both agents contain a thiol group. In addition, captopril has immunosuppressant activity. Captopril was therefore considered a potential slow-acting drug for treating rheumatoid arthritis. In an open study 15 patients with active arthritis were treated with captopril and followed for 48 weeks. Two-thirds of the patients reported improved arthritis symptoms, and significant changes were seen in several clinical and biochemical measurements, notably Ritchie articular index, clinical score, plasma viscosity, and C-reactive protein. Side-effects were generally mild and included transient taste loss, rashes, and hypotension. Only 2 patients withdrew as a result of drug intolerance.
Url:
DOI: 10.1016/S0140-6736(84)91821-X
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001575
- to stream Istex, to step Curation: 001575
- to stream Istex, to step Checkpoint: 002341
Links to Exploration step
ISTEX:C63C80BFE2A7AF30F33E0362961D682A2C250FD7Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>CAPTOPRIL: A NEW TREATMENT FOR RHEUMATOID ARTHRITIS?</title>
<author><name sortKey="Martin, M F R" sort="Martin, M F R" uniqKey="Martin M" first="M. F. R." last="Martin">M. F. R. Martin</name>
</author>
<author><name sortKey="Mckenna, F" sort="Mckenna, F" uniqKey="Mckenna F" first="F." last="Mckenna">F. Mckenna</name>
</author>
<author><name sortKey="Bird, H A" sort="Bird, H A" uniqKey="Bird H" first="H. A." last="Bird">H. A. Bird</name>
</author>
<author><name sortKey="Surrall, K E" sort="Surrall, K E" uniqKey="Surrall K" first="K. E." last="Surrall">K. E. Surrall</name>
</author>
<author><name sortKey="Dixon, J S" sort="Dixon, J S" uniqKey="Dixon J" first="J. S." last="Dixon">J. S. Dixon</name>
</author>
<author><name sortKey="Wright, V" sort="Wright, V" uniqKey="Wright V" first="V." last="Wright">V. Wright</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C63C80BFE2A7AF30F33E0362961D682A2C250FD7</idno>
<date when="1984" year="1984">1984</date>
<idno type="doi">10.1016/S0140-6736(84)91821-X</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-7P6QS6TK-W/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001575</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001575</idno>
<idno type="wicri:Area/Istex/Curation">001575</idno>
<idno type="wicri:Area/Istex/Checkpoint">002341</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002341</idno>
<idno type="wicri:doubleKey">0140-6736:1984:Martin M:captopril:a:new</idno>
<idno type="wicri:Area/Main/Merge">003655</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">CAPTOPRIL: A NEW TREATMENT FOR RHEUMATOID ARTHRITIS?</title>
<author><name sortKey="Martin, M F R" sort="Martin, M F R" uniqKey="Martin M" first="M. F. R." last="Martin">M. F. R. Martin</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University Department of Medicine, General Infirmary at Leeds, LS2 9PJ, Leeds</wicri:regionArea>
<wicri:noRegion>Leeds</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mckenna, F" sort="Mckenna, F" uniqKey="Mckenna F" first="F." last="Mckenna">F. Mckenna</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University Department of Medicine, General Infirmary at Leeds, LS2 9PJ, Leeds</wicri:regionArea>
<wicri:noRegion>Leeds</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bird, H A" sort="Bird, H A" uniqKey="Bird H" first="H. A." last="Bird">H. A. Bird</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Clinical Pharmacology Unit, Royal Bath Hospital, Harrogate, Yorkshire</wicri:regionArea>
<wicri:noRegion>Yorkshire</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Surrall, K E" sort="Surrall, K E" uniqKey="Surrall K" first="K. E." last="Surrall">K. E. Surrall</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Clinical Pharmacology Unit, Royal Bath Hospital, Harrogate, Yorkshire</wicri:regionArea>
<wicri:noRegion>Yorkshire</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Dixon, J S" sort="Dixon, J S" uniqKey="Dixon J" first="J. S." last="Dixon">J. S. Dixon</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Clinical Pharmacology Unit, Royal Bath Hospital, Harrogate, Yorkshire</wicri:regionArea>
<wicri:noRegion>Yorkshire</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wright, V" sort="Wright, V" uniqKey="Wright V" first="V." last="Wright">V. Wright</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University Department of Medicine, General Infirmary at Leeds, LS2 9PJ, Leeds</wicri:regionArea>
<wicri:noRegion>Leeds</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">The Lancet</title>
<title level="j" type="abbrev">LANCET</title>
<idno type="ISSN">0140-6736</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1984">1984</date>
<biblScope unit="volume">323</biblScope>
<biblScope unit="issue">8390</biblScope>
<biblScope unit="page" from="1325">1325</biblScope>
<biblScope unit="page" to="1328">1328</biblScope>
</imprint>
<idno type="ISSN">0140-6736</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0140-6736</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Angiotensin</term>
<term>Arthritis</term>
<term>Arthritis rheum</term>
<term>Arthritis symptoms</term>
<term>Articular index</term>
<term>Captopril</term>
<term>Captopril therapy</term>
<term>Cigarette smoke</term>
<term>Clinical improvement</term>
<term>Clinical response</term>
<term>Clinical studies</term>
<term>Clinical variables</term>
<term>Gastrointestinal tracts</term>
<term>Human cells</term>
<term>Human model screening system</term>
<term>Hydrogen peroxide</term>
<term>Hydroxyl</term>
<term>Hypertension</term>
<term>Hypertensive patients</term>
<term>Immunochemical quantitation</term>
<term>Laboratory variables</term>
<term>Lancet</term>
<term>Morning stiffness</term>
<term>Mucus</term>
<term>Mucus layers</term>
<term>Night sweats</term>
<term>Open study</term>
<term>Other saards</term>
<term>Oxygen radicals</term>
<term>Plasma viscosity</term>
<term>Potential toxicity</term>
<term>Prostaglandin</term>
<term>Prostaglandin production</term>
<term>Rank test</term>
<term>Reactive species</term>
<term>Rheumatoid</term>
<term>Rheumatoid arthritis</term>
<term>Significant changes</term>
<term>Sodium aurothiomalate</term>
<term>Such cells</term>
<term>Surface epithelium</term>
<term>Table matrix</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: Captopril, an inhibitor of angiotensin converting enzyme, is prescribed for hypertension. Its molecular structure shares features with D-penicillamine, in that both agents contain a thiol group. In addition, captopril has immunosuppressant activity. Captopril was therefore considered a potential slow-acting drug for treating rheumatoid arthritis. In an open study 15 patients with active arthritis were treated with captopril and followed for 48 weeks. Two-thirds of the patients reported improved arthritis symptoms, and significant changes were seen in several clinical and biochemical measurements, notably Ritchie articular index, clinical score, plasma viscosity, and C-reactive protein. Side-effects were generally mild and included transient taste loss, rashes, and hypotension. Only 2 patients withdrew as a result of drug intolerance.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003655 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 003655 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Merge |type= RBID |clé= ISTEX:C63C80BFE2A7AF30F33E0362961D682A2C250FD7 |texte= CAPTOPRIL: A NEW TREATMENT FOR RHEUMATOID ARTHRITIS? }}
This area was generated with Dilib version V0.6.33. |